 |
|
|
Forms 3, 4, 5
As of June 30, 2005, the directors and officers of Sangui Biotech International, Inc., had reported beneficial ownership of SGBI securities as follows:
|
Title of Class
|
Name and Address
of Beneficial Owner
|
Amount and Nature of
Beneficial Ownership
|
Percent of Class
|
|
|
|
|
|
Common Stock
|
Dr. Wolfgang Barnikol
Arndstr.8
58453 Witten
Germany
|
1,853,600
|
3.8 %
|
|
Common Stock
|
Dr. Joachim Fleing
Am Vogelherd 43
35043 Marburg
Germany
|
202,000
|
0.4 %
|
|
|
|
|
|
Common Stock
|
All Officers and Directors
as a Group (4 persons)
|
2,055,600
|
4.2 %
|
For current information regarding directors' dealings and changes in beneficial ownership please refer to the respective SEC filings.
|
|
|
|
